One-Year Outcome for Congenital Diaphragmatic Hernia: Results From the French National Register - 31/01/18
, Fabrice Michel, MD, PhD 1, Anderson D. Loundou, PhD 2, Virginie Fouquet, MD 3, Elsa Kermorvant, MD 4, Sébastien Blanc, MD 5, Elisabeth Carricaburu, MD 6, Amélie Desrumaux, MD 7, Odile Pidoux, MD 8, Alexis Arnaud, MD 9, Nicolas Berte, MD 10, Thierry Blanc, MD 11, Frederic Lavrand, MD 12, Guillaume Levard, MD 13, Isabelle Rayet, MD 14, Sylvain Samperiz, MD 15, Anne Schneider, MD 16, Marie-Odile Marcoux, MD 17, Norbert Winer, MD 18, Yann Chaussy, MD 19, Valérie Datin-Dorriere, MD 20, Quentin Ballouhey, MD 21, Aurélien Binet, MD 22, Charles Muszynski, MD 23, Jean Breaud, MD 24, Armelle Garenne, MD 25, Laurent Storme, MD, PhD 26, Julia Boubnova, MD 27on behalf of the
Center for Rare Diseases for Congenital Diaphragmatic Hernia
Abstract |
Objective |
To evaluate the status of congenital diaphragmatic hernia (CDH) management in France and to assess predictors of adverse outcomes.
Study design |
We reviewed the first-year outcome of all cases of CDH reported to the French National Register in 2011.
Results |
A total of 158 cases were included. Of these, 83% (131) were prenatally diagnosed, with a mortality rate of 39% (44 of 112) for live born infants with a known outcome at hospital discharge. Mortality increased to 47% (60 of 128) including those with termination of pregnancy and fetal loss. This contrasts with the 7% (2 of 27) mortality rate of the patients diagnosed postnatally (P = .002). Mortality worsened with 1 prenatal marker of CDH severity (OR 3.38 [1.30-8.83] P = .013) and worsened further with 2 markers (OR 20.64 [5.29-80.62] P < .001). Classic postnatal risk factors of mortality such as side of hernia (nonleft P = .001), prematurity (P < .001), low birth weight (P = .002), and size of the defect (P < .001) were confirmed. Of the 141 live births (114 prenatal and 27 postnatal diagnosis) with known outcomes, 93 (67%) survived to hospital discharge, 68 (60%) with a prenatal diagnosis and 25 (93%) with a postnatal diagnosis. The median time to hospital discharge was 34 days (IQR, 19.25-62). Of these survivors, 71 (76%) were followed up for 1 year.
Conclusions |
Despite advances in management of CDH, mortality was high and associated with prenatal risk factors. Postnatally, severe persistent pulmonary hypertension was difficult to predict and presented persistent challenges in management.
Le texte complet de cet article est disponible en PDF.Keywords : congenital diaphragmatic hernia, mortality, prognosis, outcome
Abbreviations : CDH, ECMO, FETO, FLs, LHR, o/e, TLV, TOP
Plan
| The authors declare no conflicts of interest. |
Vol 193
P. 204-210 - février 2018 Retour au numéro
Article précédent
- Patterns of Care at the End of Life for Children and Young Adults with Life-Threatening Complex Chronic Conditions
- Danielle D. DeCourcey, Melanie Silverman, Adeolu Oladunjoye, Emily M. Balkin, Joanne Wolfe
- 50 Years Ago in The Journal of Pediatrics : Differential Cyanosis in Congenital Heart Disease
- Sadagopan Srinivasan, Kothandam Sivakumar
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?